Age: 69.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Angina pectoris
Clinical narrative: she could not lean forward and she could not lean back; She is feeling really weak; her arm was a little sore, within 5 minutes she had severe chest pain/ severe pain for 2 days/ Not sure if heart attack and she had pain in her back/ severe heart pain; Dose 1 on 23Aug2021; Dose 2 on 25Aug2022/ she spread the vaccines out a year apart; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 69-year-old female patient received BNT162b2 (BNT162B2), on 25Aug2022 at 14:30 as dose 2, single (Lot number: FP7150) at the age of 69 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "COVID-19", start date: Jan2022 (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, Lot: FC3181, Anatomical location: Arm), administration date: 23Aug2021, when the patient was 68-year-old, for Covid-19 Immunization, reaction(s): "COVID-19", "COVID-19". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 25Aug2022 at 14:30, outcome "unknown", described as "Dose 1 on 23Aug2021; Dose 2 on 25Aug2022/ she spread the vaccines out a year apart"; MYOCARDIAL INFARCTION (medically significant) with onset 26Aug2022 at 09:00, outcome "recovering", described as "her arm was a little sore, within 5 minutes she had severe chest pain/ severe pain for 2 days/ Not sure if heart attack and she had pain in her back/ severe heart pain"; MOBILITY DECREASED (non-serious), outcome "unknown", described as "she could not lean forward and she could not lean back"; ASTHENIA (non-serious), outcome "unknown", described as "She is feeling really weak". The events "her arm was a little sore, within 5 minutes she had severe chest pain/ severe pain for 2 days/ not sure if heart attack and she had pain in her back/ severe heart pain", "she could not lean forward and she could not lean back" and "she is feeling really weak" required emergency room visit. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: Unknown result; Blood test: Unknown result; Electrocardiogram: Unknown result. Clinical course: No additional vaccines were administered on same date of the Pfizer suspect. Patient received the first vaccine and she spread the vaccines out a year apart. She said with her first shot there was no reaction. Nothing happened and felt like she didn't even have it. She received her second Covid Pfizer vaccine on Thursday 25Aug2022 2:30 in the afternoon and everything was fine. She was trying to drink a lot of water and she went to sleep that night. She woke up in the morning and her arm was a little sore (had slight pain in her arm) and nothing major and within 5 minutes she had severe chest pain. Pain started in the center and moved all over her chest. She did not get out of bed. She had severe pain for 2 days and this was constant pain. Not sure if heart attack and she had pain in her back. Severe heart pain. It's like she got to hold her heart for 2 days. She could not sit up, could not lie down, could not lean forward and had to sit straight up for 2 days and was still in severe pain. She could not lie down without excruciating shocking pain. When to Emergency Room by 11:00 am and she work up around 9 or 9:30 and the pain got worse. She said the hospital is not noted for being the best hospital. She had an EKG, blood work and then had to do blood work again in 2 hours and did blood pressure and she was too sick to know what was going on. She is feeling really weak and she had appointment on the 31th and not sure if the records will help. She said the chest pain has improved. Her heart is still very sore but it's not like it was. She felt like it was heart attack, to put it that way. She wants to know if there is a difference in the ingredients with her first and second dose of the Pfizer Biontech COVID19 vaccine.  Follow-up attempts are completed. No further information is expected.